By considering stability as part of the cell line selection and cell banking paradigm, we can ensure that instability problems are not observed during clinical or commercial manufacturing.
Kerstin Crowe
Advertisement
Kerstin Crowe is a research scientist II in the cell and molecular sciences group in the department of Drug Substance Development at Wyeth Biopharma
Articles by Kerstin Crowe
Advertisement
Latest Updated Articles
Advertisement
Advertisement